CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
The Reprieve Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02062398
NCT02062398N/ACompleted
CompareCT.gov

Safety and Performance of the BlueWind Medical Reprieve System for the Treatment of Patients With Peripheral Neuropathic Pain (PNP)

BlueWind Medical·interventional·Posted Feb 13, 2014·Updated Dec 30, 2019

In Brief

A clinical study evaluating The Reprieve System for Peripheral Neuropathy. Completed, enrolled 13 participants across 4 sites in 2 countries.

Detailed Summary

The current study will evaluate the safety and performance of the BlueWind Medical Reprieve System for the treatment of Chronic Painful Peripheral Neuropathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Neuropathy
CountriesBelgium, Poland
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 13, 2014
Enrollment StartMay 1, 2014
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 12.4 years ago

Interventions

The Reprieve Systemdevice

BlueWind Medical neurostimulator for the treatment of neuropathic pain